Proteome pulls out of prostate test
15 July, 2008 by Dylan Bushell-EmblingProteome Systems abandons prostate cancer test development
Stirling fishes for trout
15 July, 2008 by Dylan Bushell-EmblingStirling presents results of Loma salmonae treatment trials
Genetic Technologies gets tough
14 July, 2008 by Kate McDonaldGTG to enforce rights to BRCA patents
Prana candidate reduces Abeta levels
10 July, 2008 by Dylan Bushell-EmblingPrana research shows PBT2 reduces Abeta and improves cognition in mouse model
Mesoblast targets AMD and retinopathy
10 July, 2008 by Dylan Bushell-EmblingMesoblast's allogeneic stem cells in trial for diabetic retinopathy and age-related macular degeneration.
Medigard selects site for trials
10 July, 2008 by Dylan Bushell-EmblingGold Coast's Medigard chooses Genomics Research Centre at Griffith Uni for trials
Cytopia adds and subtracts
10 July, 2008 by Dylan Bushell-EmblingCytopia appoints new scientific advisor, closes US east coast office
Gro for Tissue Therapies
09 July, 2008 by Dylan Bushell-EmblingTissue Therapies to commence human VitroGro trials locally
First steps for Bionomics' anti-anxiety drug
09 July, 2008 by Dylan Bushell-EmblingBionomics completes GMP synthesis of anxiety drug candidate
Extra indication for VivaGel
09 July, 2008 by Dylan Bushell-EmblingStarpharma to adapt VivaGel as bacterial vaginosis treatment
Brain Resource licenses behavioural health technology
08 July, 2008 by Dylan Bushell-EmblingReaches a three-year exclusive arrangement with OptumHealth
Positive results for Select
08 July, 2008 by Dylan Bushell-EmblingSelect Vaccines' bird flu candidate promising in pre-clinical trial
Phosphagenics appoints pharma veteran
08 July, 2008 by Dylan Bushell-EmblingMichael Ashton joins Phosphagenics' board
Prana co-founder addresses US Senate
08 July, 2008 by Dylan Bushell-EmblingRudolph Tanzi provides testimony on Alzheimer's in front of the Special Committee on Ageing
